Systematic Review

Accepted on 05 Nov 2024

Exploring Research Trends and Hotspots on PCSK9 Inhibitor Studies: A Bibliometric and Visual Analysis spanning 2007 to 2023

in Cardiovascular Pharmacology and Drug Discovery

Ping Lai
Xu Shuquan
Zi-You Liu
Jia-Yuan Ling
Kejun Tian
Jianwei Yan
Dong Chen
Yi-Ming Zhong
Jinhua Xue

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1474472

Original Research

Published on 29 Oct 2024

Metabolomics revealed pharmacodynamic effects of aspirin and indobufen in patients after percutaneous transluminal angioplasty surgery

in Cardiovascular Pharmacology and Drug Discovery

Shaobo Sun
Kang Xun
Damei Li
Renjie Bao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1433643

291 views

Review

Accepted on 25 Oct 2024

Traditional Chinese Medicine for Cardiovascular Disease: Efficacy and Safety

in Cardiovascular Pharmacology and Drug Discovery

Lin Youwei
Han Yuanshan
Wang Yuhong

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1419169

Original Research

Published on 24 Oct 2024

Simultaneous determination of the combined and free concentrations of atorvastatin and its major metabolite in vitro and in vivo based on ultraﬁltration coupled with UPLC-MS/MS method: an application in a protein binding rate and metabolism ability study in uremic hemodialysis patients

in Cardiovascular Pharmacology and Drug Discovery

Ming-Chen Cao
Xin Huang
Bo-Hao Tang
Hai-Yan Shi
Yi Zheng
Wei Zhao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1461181

323 views

Review

Published on 18 Oct 2024

Research progress of sea buckthorn (Hippophae rhamnoides L.) in prevention and treatment of cardiovascular disease

in Cardiovascular Pharmacology and Drug Discovery

Yumeng Chen
Weiwei He
Hanjing Cao
Zhenzhen Wang
Jiping Liu
Bin Wang
Chuan Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1477636

738 views

Systematic Review

Published on 25 Sep 2024

The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors combined with statins in patients with hypercholesterolemia: a network meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Dong Liu
Jin Zhang
Xiaoyu Zhang
Fengli Jiang
Yiping Wu
Beibei Yang
Xinghuan Li
Xiongxiong Fan
Han Li
Yu Sun

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1454918

1,048 views

Original Research

Published on 24 Sep 2024

Causal relationship between novel antidiabetic drugs and ischemic stroke: a drug-targeted Mendelian randomization study

in Cardiovascular Pharmacology and Drug Discovery

Zongliang Yu
Xinyi Liu
Xue Feng
Xiaonan Zhang
Rui Gao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1449185

960 views

Review

Published on 23 Sep 2024

A comprehensive review of finerenone—a third-generation non-steroidal mineralocorticoid receptor antagonist

in Cardiovascular Pharmacology and Drug Discovery

Shuhui Zhai
Baisheng Ma
Weiwei Chen
Qini Zhao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1476029

1,688 views

Mini Review

Published on 11 Sep 2024

Unveiling the role of TRPA1 in cardiovascular health and disease: a mini review

in Cardiovascular Pharmacology and Drug Discovery

Islam Gellani
Chunqi Qian
Shuangtao Ma

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1416698

773 views

Review

Published on 06 Sep 2024

Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review

in Cardiovascular Pharmacology and Drug Discovery

Domingo Pascual-Figal
Antoni Bayes-Genis

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1439696

3,589 views

Editorial

Published on 04 Sep 2024

Editorial: Nutraceuticals in cardiovascular diseases and their associated risk conditions

in Cardiovascular Pharmacology and Drug Discovery

Lamiaa Ahmed
Naufal Zagidullin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1468355

421 views

Brief Research Report

Published on 30 Aug 2024

One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy

in Cardiovascular Pharmacology and Drug Discovery

Daniel Seung Kim
Emily L. Chu
Emily E. Keamy-Minor
Ishan Dhananjay Paranjpe
Wilson L. Tang
Jack W. O’Sullivan
Yaanik B. Desai
Michael B. Liu
Elise Munsey
Kimberly Hecker

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1429230

2,226 views

Systematic Review

Published on 15 Aug 2024

Safety and efficacy of aspirin and indobufen in the treatment of coronary heart disease: a systematic review and meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Xiaochen Zhang
Qiaoyan Yan
Jiao Jiang
Hua Luo
Yu Ren

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1412944

2,259 views

Original Research

Published on 25 Jul 2024

Identification and validation of CCL5 as a key gene in HIV infection and pulmonary arterial hypertension

in Cardiovascular Pharmacology and Drug Discovery

Mengyue Yang
Wen Bi
Zhijie Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1417701

2,443 views

Original Research

Published on 16 Jul 2024

Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy

in Cardiovascular Pharmacology and Drug Discovery

Anselm A. Derda
Malin Abelmann
Kristina Sonnenschein
Jan-Thorben Sieweke
Udo Bavendiek
Johann Bauersachs
Thomas Thum
Dominik Berliner

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1403422

1,454 views
1 citation

Review

Published on 08 Jul 2024

The potential therapeutic value of the natural plant compounds matrine and oxymatrine in cardiovascular diseases

in Cardiovascular Pharmacology and Drug Discovery

Shanjiang Chen
Shu Wu
Bin Lin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1417672

1,124 views

Navigation group

Articles

Exploring Research Trends and Hotspots on PCSK9 Inhibitor Studies: A Bibliometric and Visual Analysis spanning 2007 to 2023

Metabolomics revealed pharmacodynamic effects of aspirin and indobufen in patients after percutaneous transluminal angioplasty surgery

Traditional Chinese Medicine for Cardiovascular Disease: Efficacy and Safety

Simultaneous determination of the combined and free concentrations of atorvastatin and its major metabolite in vitro and in vivo based on ultraﬁltration coupled with UPLC-MS/MS method: an application in a protein binding rate and metabolism ability study in uremic hemodialysis patients

Research progress of sea buckthorn (Hippophae rhamnoides L.) in prevention and treatment of cardiovascular disease

The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors combined with statins in patients with hypercholesterolemia: a network meta-analysis

Causal relationship between novel antidiabetic drugs and ischemic stroke: a drug-targeted Mendelian randomization study

A comprehensive review of finerenone—a third-generation non-steroidal mineralocorticoid receptor antagonist

Unveiling the role of TRPA1 in cardiovascular health and disease: a mini review

Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review

Editorial: Nutraceuticals in cardiovascular diseases and their associated risk conditions

One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy

Safety and efficacy of aspirin and indobufen in the treatment of coronary heart disease: a systematic review and meta-analysis

Identification and validation of CCL5 as a key gene in HIV infection and pulmonary arterial hypertension

Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy

The potential therapeutic value of the natural plant compounds matrine and oxymatrine in cardiovascular diseases